James Stoll, PhD
James Stoll, PhD
1300 S Coulter St
Amarillo TX 79106-1712
Dr Stoll received a BS with Honors degree in Chemistry from New Mexico State University. He received his PhD in Biochemistry from the School of Public Health, The Johns Hopkins University. Dr Stoll carried out post-graduate research at the NIH, first in the National Institute on Alcohol Abuse and Alcholism, then in the National Institute on Aging. Dr Stoll joined Texas Tech in 1996 as a Founding Faculty member in the School of Pharmacy
My Reseach Interests are in the area of Molecular Neurochemistry. A long-term project in the lab is to understand the biochemistry of nutrient transporters in brain function. These transporters and their substrates may effect neural disease through effects on neuroinflammation. More recent research in the lab is involved in understanding how nutrient metabolism may effect seizure threshold and risk for seizures in animal models of epilepsy. Member of the Texas Tech Center for Blood-Brain Barrier Research
Biochemical and Molecular foundations of human and animal health. Neurochemical and Neurophysiological mechanisms or neurological/psychiatric disorders.
- Bennett KM, Liu J, Hoelting C, Stoll J. Expression and analysis of two novel rat organic cation transporter homologs, SLC22A17 and SLC22A23.. Molecular Cellular Biochemistry 2011;352(1-2):143-54.
- Bennett KM, Hoelting C, Martin C, Stoll J. Estrogen effects on high-affinity choline uptake in primary cultures of rat basal forebrain. Neurochemical Research 2009;34(2):205-14.
- Kiewert C, Hartmann J, Stoll J, Thekkumkara TJ, Van der Schyf CJ, Klein J. NGP1-01 is a brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels.. Neurochem Res. 2006;31(3):395-9.